Exploring Panchkarma Treatment Modalities for Managing Motor Neuron Disease and ALS - A Review

Keywords: Ayurveda, Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), Neurodegenerative Disorders, Panchkarma, Vatavyadhi

Abstract

Introduction: Motor Neuron Disease (MND), particularly Amyotrophic Lateral Sclerosis (ALS), represents a complex and progressive neurodegenerative condition characterized by the degeneration of motor neurons in the nervous system. These neurons, crucial for voluntary muscle activity, deteriorate progressively, leading to muscle weakness, atrophy and eventual paralysis. ALS, the most common form of MND, affects both upper and lower motor neurons, resulting in a combination of symptoms such as muscle twitching (fasciculations), spasticity and significant weakness. MND incidence is approximately 2 / 100,000 people annually, with ALS typically presenting in most cases. Methods: The pathophysiology of ALS involves a cascade of cellular and molecular events including the accumulation of neurofilaments, the formation of protein aggregates and mitochondrial dysfunction, all contributing to the death of motor neurons. Despite extensive research, the aetiology remains largely unclear, though genetic and environmental factors are considered contributors. Result & Conclusion: In contrast, Ayurveda views MND/ALS through the lens of Vatavyadhi, a disorder primarily involving Vata Dosha. It correlates MND/ALS with Dhatukshayajanya Sarvangavata, implicating the depletion of Dhatu and an imbalance in the Dosha. By addressing imbalances in the Dosha, Dhatu and Srotas, Ayurveda offers a holistic framework that may complement conventional treatments, improve patient outcomes, and enhance quality of life. Future research is needed to validate the efficacy of these approaches and establish integrative care models that merge traditional and modern medical practices.

Downloads

Download data is not yet available.

References

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review). Neurology. 2009 Dec 15;73(24):2134.

Nelson LM, McGuire V. Epidemiology of amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis. London: CRC Press; 2021 [cited 2024 Oct 01]. p. 25–41. Available from: http://dx.doi.org/10.1201/9781003076445-3

Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011 Mar;377(9769):942–55.

Hu Y, Chen W, Wei C, Jiang S, Li S, Wang X, et al. Pathological mechanisms of amyotrophic lateral sclerosis. Neural Regen Res. 2023 Aug 14;19(5):1036–44.

Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001 May 31;344(22):1688–700.

Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2017 Jul 26;2017(7).

Clinical features of amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis. Jenny Stanford Publishing; 2016 [cited 2024 Oct 01]. p. 10–33. Available from: http://dx.doi.org/10.1201/b15632-3

Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001 Nov;2(11):806–19.

Familial ALS and genetic approaches to ALS. In: Amyotrophic Lateral Sclerosis. CRC Press; 2005 [cited 2024 Oct 01]. p. 173–98. Available from: http://dx.doi.org/10.1201/b14133-11

Ha J, Ringel SP, Oskarsson B. Progressive muscular atrophy. Int Neurol. 2016 Apr 22; p. 447–8.

Gotkine M, Argov Z. Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis. Arch Neurol. 2007 Oct 1;64(10):1545.

Garcia Santibanez R, Scelsa S. Differences in denervation patterns between patients with limb onset and bulbar onset ALS (P4.096). Neurology. 2014 Apr 8;82(10 Suppl).

Reiss J, King RR. The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration. Degener Neurol Neuromuscul Dis. 2013 May; p. 23.

Darras BT, Finkel RS. Natural history of spinal muscular atrophy. In: Spinal Muscular Atrophy. Elsevier; 2017 [cited 2024 Oct 10]. p. 399–421. Available from: http://dx.doi.org/10.1016/b978-0-12-803685-3.00025-2

Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015 Oct;386(10004):1672–82.

Jinka M, Chaudhry V. Treatment of multifocal motor neuropathy. Curr Treat Options Neurol. 2014 Jan 7;16(2).

Wohnrade C, Seeliger T, Gingele S, Bjelica B, Skripuletz T, Petri S. Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy. J Neurol. 2024 Apr 29;271(7):4441–52.

Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011 Mar;377(9769):942–55.

Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001 May 31;344(22):1688–700.

De Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000 Mar;23(3):344–52.

Sawalha K, Gonzalez-Toledo E, Hussein O. Role of magnetic resonance imaging in diagnosis of motor neuron disease: literature review and two case illustrations. Perm J. 2019 Mar;23(1).

Bhishagratna KL, editor. An English Translation of the Sushruta Samhita. Varanasi: Chowkhambha Sanskrit Series; 1996.

Manohar PR. Critical review and validation of the concept of Āma. Anc Sci Life. 2012;32(2):67.

Narine A, Mangal G. An in-depth review of Ayurvedic basti karma (medicated enema). Int J Res AYUSH Pharm Sci. 2020 Jul 15; p. 388–91.

Narine A, Mangal G. Conceptual study of nasya karma and its various applications. Int Ayurvedic Med J. 2021; p. 381–7. Available from: http://dx.doi.org/10.46607/iamj1610022022

Kulamarva K, Shivakumar V, Chikkanna U, Ramakrishna KK, Bhargav H, Varambally S. Role of Ayurveda in the management of psychotic disorders: a systematic review of clinical evidence. J Ayurveda Integr Med. 2023 May;14(3):100720.

Garg R. Shirodhara healing – an ultimate Ayurvedic holistic remedy. Int J Complement Altern Med. 2015 Aug 24;1(4).

Narine A, Moazzamipeiro F, Vedpathak S. An introduction to Keraliya Panchakarma – a systematic review. Asian Pac J Health Sci. 2023;10(4):1–6. Available from: http://dx.doi.org/10.21276/apjhs.2023.10.4.01

Narine A, Moazzamipeiro F, Vedpathak S. An introduction to Keraliya Panchakarma – a systematic review. Asian Pac J Health Sci. 2023;10(4):1–6. Available from: http://dx.doi.org/10.21276/apjhs.2023.10.4.01

CITATION
DOI: 10.21760/jaims.10.7.23
Published: 2025-08-02
How to Cite
1.
Avvinish Annant Narine, Gopesh Mangal. Exploring Panchkarma Treatment Modalities for Managing Motor Neuron Disease and ALS - A Review. J Ayurveda Integr Med Sci [Internet]. 2025Aug.2 [cited 2025Aug.14];10(7):154 -161. Available from: https://www.jaims.in/jaims/article/view/4608
Section
Review Article